China: Merial invests US $ 70 million to expand its poultry vaccine facility in Nanchang
12.10.2009
Merial, the Animal Health division of the sanofi-aventis Group, announced that Merial Animal Health Co. (China) held a ground-breaking ceremony for an expansion project at its plant located in the Nanchang Hi-tech Development Zone, China. The facility in Nanchang produces poultry vaccines for the domestic Chinese market. Upon completion of the expansion project, which earmarks an estimated total investment of over 70 million US dollars, the production capacity of the Nanchang plant will double. The new facility covers a land of 50,000 square meters, with a phase I floor area of nearly 30,000 square meters.
Merial has been operating in China for nearly 20 years.